The side effect prediction models performed at 65-68% AUC, which is statistically meaningful but not yet at a level that would change individual patient decisions
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test reveals predispositions in metabolic and antioxidant pathways, including variants affecting glutathione synthesis (GCLC), oxidative stress resilience (SOD2, CAT), and thyroid autoimmunity (HLA, CTLA4)
They reduce inflammation and provide analgesic effects
Some may even start feeling better sooner because the B12 goes straight into your bloodstream, making it work faster
Ipamorelin selectivity characterisation: Landmark studies by Raun, Sehested Hansen, and colleagues at Novo Nordisk characterised Ipamorelin as the first GHRP with a selectivity profile resembling GH-releasing hormone producing robust GH release with essentially no elevation of cortisol, ACTH, or prolactin at doses producing maximal GH responses